NASDAQ:APLS - Apellis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$19.70 0.00 (0.00 %)
(As of 03/22/2019 01:50 AM ET)
Previous Close$19.70
Today's Range$19.08 - $19.78
52-Week Range$11.45 - $32.00
Volume245,955 shs
Average Volume662,008 shs
Market Capitalization$1.24 billion
P/E Ratio-8.42
Dividend YieldN/A
Beta0.37

Analyst Ratings

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Apellis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $42.20, suggesting that the stock has a possible upside of 114.21%. The high price target for APLS is $57.00 and the low price target for APLS is $34.00. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.803.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $42.20$41.40$41.40$38.20
Price Target Upside: 114.21% upside208.04% upside190.73% upside103.08% upside

Apellis Pharmaceuticals (NASDAQ:APLS) Consensus Price Target History

Price Target History for Apellis Pharmaceuticals (NASDAQ:APLS)

Apellis Pharmaceuticals (NASDAQ:APLS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/28/2019Cantor FitzgeraldSet Price TargetBuy$57.00HighView Rating Details
1/23/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$34.00HighView Rating Details
1/8/2019B. RileyInitiated CoverageBuy$40.00LowView Rating Details
12/6/2018CitigroupBoost Price TargetBuy$34.00 ➝ $40.00MediumView Rating Details
8/1/2018CowenReiterated RatingBuy$40.00MediumView Rating Details
12/4/2017Evercore ISIInitiated CoverageOutperformHighView Rating Details
(Data available from 3/22/2017 forward)
This page was last updated on 3/22/2019 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel